Mark L. Offerhaus
Directeur Général chez Micreos BV
Profil
Mark L.
Offerhaus founded Eco Investment Partners BV in 2005.
Mr. Offerhaus also founded Micreos BV, where he worked as Chief Executive Officer.
Mr. Offerhaus also formerly worked at Micreos Human Health BV, as Chief Executive Officer from 2005 to 2023, Exponential Biotherapies, Inc., as Director in 2004, ING Groep NV, as Principal, and Enuenu Life Insurance Co., Ltd., as President.
Mr. Offerhaus received his graduate degree from the University of Leiden.
Postes actifs de Mark L. Offerhaus
| Sociétés | Poste | Début |
|---|---|---|
Micreos BV
 Micreos BV Pharmaceuticals: GenericHealth Technology Micreos BV develops phage-based products against specific dangerous bacteria. It offers human health, food safety, agriculture and animal health products. The company was founded by Mark Offerhaus and is headquartered in Wageningen, the Netherlands. | Directeur Général | - |
| Eco Investment Partners BV | Corporate Officer/Principal | 01/01/2005 |
Anciens postes connus de Mark L. Offerhaus
| Sociétés | Poste | Fin |
|---|---|---|
Micreos Human Health BV
 Micreos Human Health BV BiotechnologyHealth Technology Micreos Human Health BV operates as biotechnology company, which engages in the provision of anti-bacterial products. It develops Gladskin, a technology that targets the harmful Staphylococcus aureus-bacterium, and eaves the good bacteria - essential for a healthy skin. The company is headquartered in The Hague, the Netherlands. | Directeur Général | 01/06/2023 |
Exponential Biotherapies, Inc.
 Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Exponential Biotherapies, Inc. discovers and develops drugs. It provides small molecule drugs to treat an inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections. The company was founded on July 31, 1996 and is headquartered in New York, NY. | Directeur/Membre du Conseil | 01/01/2004 |
| ING GROEP N.V. | Corporate Officer/Principal | - |
Enuenu Life Insurance Co., Ltd.
 Enuenu Life Insurance Co., Ltd. Life/Health InsuranceFinance Part of ING Groep NV, Enuenu Life Insurance Co., Ltd. is a company based in Tokyo, Japan. The CEO of the Japanese company is Frank Eijsink. | President | - |
Formation de Mark L. Offerhaus
| University of Leiden | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ING GROEP N.V. | Finance |
| Entreprise privées | 5 |
|---|---|
Exponential Biotherapies, Inc.
Exponential Biotherapies, Inc. Pharmaceuticals: MajorHealth Technology Exponential Biotherapies, Inc. discovers and develops drugs. It provides small molecule drugs to treat an inflammatory disorders, such as acute kidney injury, septic shock, radiation sickness, and avian influenza infections. The company was founded on July 31, 1996 and is headquartered in New York, NY. | Health Technology |
Micreos BV
Micreos BV Pharmaceuticals: GenericHealth Technology Micreos BV develops phage-based products against specific dangerous bacteria. It offers human health, food safety, agriculture and animal health products. The company was founded by Mark Offerhaus and is headquartered in Wageningen, the Netherlands. | Health Technology |
Enuenu Life Insurance Co., Ltd.
Enuenu Life Insurance Co., Ltd. Life/Health InsuranceFinance Part of ING Groep NV, Enuenu Life Insurance Co., Ltd. is a company based in Tokyo, Japan. The CEO of the Japanese company is Frank Eijsink. | Finance |
Micreos Human Health BV
Micreos Human Health BV BiotechnologyHealth Technology Micreos Human Health BV operates as biotechnology company, which engages in the provision of anti-bacterial products. It develops Gladskin, a technology that targets the harmful Staphylococcus aureus-bacterium, and eaves the good bacteria - essential for a healthy skin. The company is headquartered in The Hague, the Netherlands. | Health Technology |
| Eco Investment Partners BV |
